Wisconsin Department of Health Services
Press Release

Majority of Wisconsin Lung Disease Patients Who Reported Vaping Cite THC Products

The investigation of lung disease among people who reported vaping is ongoing

By - Aug 29th, 2019 01:11 pm

In the Wisconsin investigation of people with lung disease who reported vaping, 89% of the 27 cases interviewed so far reported using e-cigarettes or other vaping devices to inhale THC products, such as waxes and oils, the Wisconsin Department of Health Services announced today. THC is the active ingredient in marijuana. While most cases have reported vaping THC products, DHS is continuing to investigate all possible causes. The connection to THC products is based on interviews with cases, and the agency is working with FDA to determine the contents of used vaping products.

“Vaping cartridges containing THC may include chemicals or additives that are unknown, unregulated, and unsafe,” said Department of Health Services Secretary-designee Andrea Palm. “We strongly urge people not to vape.”

Health officials are continuing to conduct interviews with new patients as part of this investigation. Currently there are 32 cases, with 11 patients whose cases need further investigation. Fourteen counties now have cases, including: Dane, Dodge, Door, Green, Kenosha, La Crosse, Milwaukee, Portage, Racine, Sauk, Walworth, Washington, Waukesha, and Winnebago. No deaths have been reported in Wisconsin.

The 32 cases include both confirmed and probable cases. A case is defined as a person who had a history of vaping and developed a severe lung disease, and did not have any infection or other causes for their illness. A probable case includes many of these factors and is likely to be confirmed, but more information is needed for confirmation. We continue to gather information from the 11 patients whose cases require further investigation.

This is a complex and ongoing investigation, and we are working to gather information about the products used, collect products for testing, and investigate new cases. Our investigation team has worked closely with FDA to coordinate testing, but we have not received results from those tests. We are also working with CDC, which is coordinating a national response to the nearly 200 illnesses in at least 22 other states. We will continue to provide updates when new information becomes available.

Anyone experiencing unexplained shortness of breath, chest pain, cough, nausea, vomiting, fever, and weight loss should talk to their doctor. People can learn more about e-cigarettes and vaping products—including what they look like, their health risks for youth, and how to talk to kids about them—at tobaccoischanging.com(link is external). There are FDA-approved medications to help tobacco users quit. Call 1-800-QUIT NOW for free help.

The latest updates on this disease investigation can be found on the Outbreaks and Investigations page of the DHS website.

Today from 1–3 p.m., Dr. Jon Meiman, Chief Medical Officer in the Bureau of Environmental and Occupational Health, will be available to answer media questions about this investigation. Media inquiries should be directed to DHSMedia@dhs.wisconsin.gov(link sends e-mail) or call the media line at 608-266-1683

Mentioned in This Press Release

Recent Press Releases by Wisconsin Department of Health Services

Wisconsin COVID-19 Vaccine Registry Launching March 1

Pilot Locations Will Begin Testing Software February 22

Wisconsin Receives 988 State Planning Grant

Funding to be used to prepare Wisconsin for the National Suicide Prevention Lifeline’s 988 calling code, effective July 2022

Leave a Reply

You must be an Urban Milwaukee member to leave a comment. Membership, which includes a host of perks, including an ad-free website, tickets to marquee events like Summerfest, the Wisconsin State Fair and the Florentine Opera, a better photo browser and access to members-only, behind-the-scenes tours, starts at $9/month. Learn more.

Join now and cancel anytime.

If you are an existing member, sign-in to leave a comment.

Have questions? Need to report an error? Contact Us